VAL Huurman, JS Kalpoe, P van de Linde, N … - Diabetes care, 2006 - Am Diabetes Assoc OBJECTIVE—Simultaneous pancreas-kidney (SPK) transplantation in type 1
diabetic patients requires immunotherapy against allo- and autoreactive T-cells.
Cytomegalovirus (CMV) infection is a major cause for morbidity after ... Cited by 15 - Related articles - BL Direct - All 5 versions
RJ Stratta, RR Alloway, A Lo, EE Hodge - Transplantation proceedings, 2005 - Elsevier This is a report of outcomes at 36 months of a prospective, multicenter study
comparing the safety and efficacy of two dosing regimens of daclizumab with no
antibody induction in simultaneous kidney–pancreas transplant (SKPT) ... Cited by 12 - Related articles - All 3 versions
J Rogers, RJ Stratta, A Lo, RR Alloway - Transplantation proceedings, 2005 - Elsevier The aim of this study was to determine the impact of ethnicity on the major
endpoints of a prospective, multi-center, randomized trial of 2 dosing regimens
of daclizumab compared with no antibody induction in simultaneous kidney- ... Cited by 3 - Related articles - All 3 versions
J Rogers, RJ Stratta, RR Alloway, A Lo, EE … - Transplantation proceedings, 2004 - Elsevier The influence of ethnicity on the outcome of simultaneous kidney–pancreas
transplantation (SKPT) is controversial. The aim of this study was to determine
the impact of ethnicity on the major endpoints of a prospective, ... Cited by 5 - Related articles - All 8 versions
GW Burke III, DB Kaufman, JM Millis, AO … - Transplantation, 2004 - journals.lww.com Burke, George W. III; Kaufman, Dixon B.; Millis, J. Michael; Gaber, A. Osama;
Johnson, Christopher P.; Sutherland, David ER; Punch, Jeffrey D.; Kahan, Barry
D.; Schweitzer, Eugene; Langnas, Alan; Perkins, James; Scandling, John; ... Cited by 28 - Related articles - BL Direct - All 5 versions
J Rogers, PK Baliga, KD Chavin, A Lin, O … - American Journal of Transplantation, 2003 - medscape.com The influence of ethnicity on outcome of simultaneous pancreas-kidney
transplantation (SPK) is poorly defined. After excluding technical failures, we
retrospectively reviewed 96 consecutive SPKs (63 Caucasians [C], 33 African- ... Cited by 8 - Related articles - BL Direct - All 5 versions
V Douzdjian, LR Thacker, JW Blanton - Clinical transplantation, 1997 - ncbi.nlm.nih.gov In this study we analyze the South-Eastern Organ Procurement Foundation (SEOPF)
experience with kidney and kidney-pancreas transplantation in IDDM recipients
and evaluate the impact of racial disparity on patient and graft outcome. ... Cited by 9 - Related articles - BL Direct
D Cantarovich, G Karam, M Giral-Classe, M … - Kidney international, 1998 - nature.com The average follow-up was 36 months in both groups (range 9 to 60 months). No
patient was excluded from the study. Although the percentage of patients with
adverse events was higher in the ATG group (80 vs. 40%, P < 0.01), none of ... Cited by 34 - Related articles - BL Direct - All 6 versions
M Mestre, J Bas, J Alsina, JM Grinyo, E … - Transplantation proceedings, 1999 - Elsevier Antilymphocyte polyclonal and monoclonal antibodies (MAbs) are potent
immunosuppressive agents used as induction or rescue therapy in organ
transplantation (Tx), and they produce a rapid and intense depletion of ... Cited by 10 - Related articles - BL Direct - All 5 versions
R Zhang, S Florman, S Devidoss, A Zarifian, … - Clinical Transplantation, 2007 - interscience.wiley.com Abstract: Interleukin-2 receptor (IL2R) antibody has emerged as an attractive
induction therapy for organ transplant. However, the long-term outcome of
basiliximab induction in simultaneous pancreas and kidney (SPK) transplant ... Cited by 2 - Related articles - BL Direct - All 3 versions
